First breast session at #ESMO26 highlights how China is developing novel drugs at rapid speed.

Dr Michelle Li· @michelle_li · X·2026-10-23 20:19· 2 天前评分70

正文 · 原文

Positive PFS results with HER2-directed ADCs (HORIZON-Breast06 + APEX-Breast01), but neither compare to current SoC of T-DXd.

Fights for market share, but does it push the needle?

272 浏览 · 2 赞 · 2 转发 · 0 回复

会议摘要

LBA13按 Proffered paper 1: Breast cancer, early and advanced stage 对上

Trastuzumab rezetecan (SHR-A1811) in HER2-low advanced breast cancer (BC): A randomized, phase 3 study (HORIZON-Breast06)

来源：Dr Michelle Li · x.com